SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 16, 2014, reporting events occurring on October 6, 2014. The filing addresses Item 5.02 regarding the departure of a director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Director Resignation: Kalyanam Skivkumar, M.D. Ph.D., submitted his resignation as a member of the Board of Directors on October 6, 2014.
- Acceptance: The Board accepted the resignation on October 14, 2014.
- Reason: The resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Dr. Skivkumar's departure.
- Confirm if a replacement director has been nominated or elected.
- Review subsequent filings for any impact on the Company's strategic direction or regulatory approvals.